Skip to content

HEALTHIER CHOICES MANAGEMENT CORP.: 10-Q filed 2025-11-06

What HEALTHIER CHOICES MANAGEMENT CORP. reported in its quarterly report filed 2025-11-06 (fiscal Q3 2025): 37 published measures, 95 facts as tagged in accession 0001493152-25-021113.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-06
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-021113 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HEALTHIER CHOICES MANAGEMENT CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-301,525,134USD
At 2024-12-312,220,449USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-304,859,028USD
At 2024-12-312,670,507USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-4,444,994USD
At 2025-06-30-3,491,464USD
At 2024-12-31-1,561,158USD
At 2024-09-30-520,253USD
At 2024-06-303,652,124USD
At 2023-12-316,758,116USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-301,121,597USD
At 2024-12-311,193,567USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,076,113USD92
2025-01-01 to 2025-09-30-6,251,586USD273
2024-07-01 to 2024-09-30-4,347,031USD92
2024-01-01 to 2024-09-30-9,714,854USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-3,058,181USD273
2024-01-01 to 2024-09-30-2,033,153USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-09-3047,185USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-07-01 to 2025-09-30199USD92
2025-01-01 to 2025-09-302,979USD273
2024-07-01 to 2024-09-3052USD92
2024-01-01 to 2024-09-30345USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-302,532,979USD273
2024-01-01 to 2024-09-304,404,912USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-4,918,865USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-81,287,181USD
At 2024-12-31-75,035,595USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-30481,266,632,384shares92
2025-01-01 to 2025-09-30481,266,632,384shares273
2024-07-01 to 2024-09-30480,092,719,341shares92
2024-01-01 to 2024-09-30479,168,092,238shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-30481,266,632,384shares92
2025-01-01 to 2025-09-30481,266,632,384shares273
2024-07-01 to 2024-09-30480,092,719,341shares92
2024-01-01 to 2024-09-30479,168,092,238shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-309,887USD
At 2024-12-3180,541USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,367,751USD273
2024-01-01 to 2024-09-303,484,416USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,084,997USD92
2025-01-01 to 2025-09-30-6,258,019USD273
2024-07-01 to 2024-09-30-2,143,405USD92
2024-01-01 to 2024-09-30-6,312,691USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-301,317,948USD
At 2024-12-311,948,822USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-304,859,028USD
At 2024-12-312,669,177USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-30166,682USD
At 2024-12-31158,151USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-30199USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,085,196USD92
2025-01-01 to 2025-09-306,235,686USD273
2024-07-01 to 2024-09-302,143,442USD92
2024-01-01 to 2024-09-306,312,846USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-3038,040USD
At 2024-12-3140,460USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30199USD92
2025-01-01 to 2025-09-30-22,333USD273
2024-07-01 to 2024-09-3037USD92
2024-01-01 to 2024-09-30155USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-30481,266,632,384shares
At 2024-12-31478,266,632,384shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-301,221,597USD
At 2024-12-311,746,799USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-3028,715,524USD
At 2024-12-3125,347,774USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-302,897USD
At 2024-12-314,435USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-3092,473USD
At 2024-12-31194,497USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-3082,586USD
At 2024-12-31113,956USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-09-3027,720USD
At 2024-12-3128,500USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,000USD92
2025-01-01 to 2025-09-307,000USD273
2024-07-01 to 2024-09-307,000USD92
2024-01-01 to 2024-09-3019,000USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-07-01 to 2025-09-3011,000USD92
2025-01-01 to 2025-09-3033,000USD273
2024-07-01 to 2024-09-3010,000USD92
2024-01-01 to 2024-09-3030,000USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,070USD273
2024-07-01 to 2024-09-30260,000USD92
2024-01-01 to 2024-09-30260,000USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-308,884USD92
2025-01-01 to 2025-09-306,433USD273
2024-07-01 to 2024-09-30274,762USD92
2024-01-01 to 2024-09-30373,396USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-30582USD273
2024-01-01 to 2024-09-3011,551USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30199USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-2,420USD273
2024-01-01 to 2024-09-30-86USD274

Inspect the source

Entity
HEALTHIER CHOICES MANAGEMENT CORP. / CIK 0000844856
Captured
2026-09-19T15:09:31.473Z
SEC response SHA-256
c494efabb02127267bba7137044383ebe74e06634e5d8fa5ac99adcdd4c2cf68

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000844856.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))